Updated Opportunistic Infection Guidelines Add Info on IRIS, Hepatitis, Drug Interactions
- Details
- Category: HIV Treatment Guidelines
- Published on Thursday, 09 May 2013 00:00
- Written by Liz Highleyman

On May 7 the National Institutes of Health, Centers for Disease Control and Prevention, and HIV Medicine Association of the Infectious Diseases Society of Americaannounced the release of revised Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents, updating the previous version from 2009.
The update includes:
- New information about diagnosis and management of immune reconstitution inflammatory syndrome (IRIS), with guidance for managing IRIS related to each opportunistic infection including tuberculosis and cryptococcosis.
- Updated information about management of hepatitis B and C in people with HIV.
- Revised information on immunization strategies, reflecting new data and new vaccines for pneumococcal disease and human papillomavirus (HPV).
- Updated drug interaction information focusing on antiretroviral drugs approved since the last OI guidelines revision in 2009.
The full Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents are available online.
The guidelines panel is accepting comments on the revision until May 21, 2013. Comments may be sent to JLIB_HTML_CLOAKING , with the subject line "Comments on Adult and Adolescent OI Guidelines."
5/9/13
Sources
National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association of the Infectious Disease Society of America. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Updated May 7, 2013.
U.S. Department of Health and Human Services. Updated Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Released. AIDSinfo At-a-Glance. May 7, 2013.